Ftse Mib
33.490,79
0,23%
DAX
19.885,92
1,31%
S&P 500
5.998,74
0,00%
NASDAQ
19.218,17
0,00%
Bitcoin
95.614,79
-1,69%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Kane Biotech Inc (KNE) Kane Biotech Inc (KNE) Notizie

Kane Biotech Inc

KNE
0,125
0,00 (0,00%)
02 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: TSX Venture
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
28/11/202422:15GLOBEKane Biotech Announces Third Quarter 2024 Financial Results
27/11/202414:30GLOBEKane Biotech Announces Change in US Distribution Partner for..
21/11/202422:30GLOBEKane Biotech to Release Third Quarter 2024 Financial Results..
14/11/202419:10GLOBEKane Biotech Announces Health Canada Approval of..
14/11/202414:30GLOBEKane Biotech Provides Investor Update Following FB..
12/11/202419:32PRNCAL'Organisme canadien de réglementation des investissements..
12/11/202419:27PRNCACanadian Investment Regulatory Organization Trade Resumption..
12/11/202419:08GLOBEKane Biotech Announces Agreement to Acquire FB Dermatology
12/11/202419:05PRNCASuspension de la négociation par l'Organisme canadien de..
12/11/202419:01PRNCACanadian Investment Regulatory Organization Trading Halt -..
23/10/202414:30GLOBEKane Biotech Announces Donation of revyve™ Antimicrobial..
17/10/202414:30GLOBEKane Biotech Announces Exclusive Distribution Agreement With..
03/10/202414:30GLOBEKane Biotech to Participate in a Multinational Corporate..
26/9/202414:30GLOBEKane Biotech Announces Attendance at Upcoming Wound Care..
12/9/202414:30GLOBEKane Biotech Announces Exercise of Warrants
29/8/202422:15GLOBEKane Biotech Announces Second Quarter 2024 Financial Results
29/8/202414:30GLOBEKane Biotech Announces new DispersinB® Publication in..
28/8/202414:40GLOBEKane Biotech Announces Distribution Agreement with Qatar..
22/8/202422:30GLOBEKane Biotech to Release Second Quarter 2024 Financial..
22/8/202414:30GLOBEKane Biotech Announces Distribution Agreement with Razan..
13/8/202414:30GLOBEKane Biotech Receives Funding Support to Expand the revyve™..
23/7/202414:30GLOBEKane Biotech Receives FDA Approval to Increase Dosage..
17/7/202414:30GLOBEKane Biotech Receives ISO 13485:2016 MDSAP Quality..
15/7/202414:30GLOBEKane Biotech Announces Issuance of Restricted Share Units
11/7/202414:30GLOBEKane Biotech Signs Worldwide License Agreement with Omni..
27/6/202414:30GLOBEKane Biotech Makes First Commercial Sale of revyve™..
25/6/202414:30GLOBEKane Biotech Signs Worldwide License Agreement with..
23/5/202422:15GLOBEKane Biotech Announces First Quarter 2024 Financial Results
16/5/202414:00GLOBEKane Biotech to Release First Quarter 2024 Financial Results..
15/5/202414:00GLOBEKane Biotech Expands its Wound Care Portfolio with Patented..
16/4/202415:15GLOBEKane Biotech to Host Investor Webinar
15/4/202417:07APSDual Listed Biotech Firm Achieves Sale of Animal Health..
15/4/202415:15GLOBEKane Biotech Announces Closing of the Sale of STEM Animal..
11/4/202416:03PRNCAL'Organisme canadien de réglementation des investissements..
11/4/202416:00PRNCACanadian Investment Regulatory Organization Trade Resumption..
11/4/202415:45GLOBEKane Biotech Announces Agreement in Principle for the Sale..
11/4/202415:07PRNCASuspension de la négociation par l'Organisme canadien de..
11/4/202415:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
26/3/202421:05GLOBEKane Biotech Announces Fourth Quarter and Full Year 2023..
20/3/202413:30GLOBEKane Biotech Extends Exclusivity Period on its Offer for its..
19/3/202421:10GLOBEKane Biotech to Release Fourth Quarter and Full Year 2023..
08/3/202415:00GLOBEKane Biotech Receives Bioscience Association Manitoba..
22/2/202414:00GLOBEDr. Robert Huizinga Elected to the Kane Biotech Board and..
31/1/202414:30GLOBEKane Biotech Files New Patent on revyve™ Antimicrobial Wound..
25/1/202418:03GLOBEKane Biotech to Present its revyve™ Antimicrobial Wound Gel..
18/1/202422:30GLOBEKane Biotech Announces Special Meeting of Shareholders
29/12/202320:33GLOBEKane Biotech Announces Correction to Press Release
28/12/202322:05GLOBEKane Biotech Announces Amendment to its Credit Facility
20/12/202314:29GLOBEKane Biotech Receives Offer for its Interest in STEM Animal..
Apertura: Min: Max:
Chiusura: 0,125

La tua Cronologia

TSXV
KNE
Kane Biotech
TG
CNP
Ingredion
TSXV
BCF.RT
Builders Capital Mortgage
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network